AstraZeneca PLC (AZN) vs RTX Corporation (RTX)
AZN leads on 12 of 17 compared metrics.
A side-by-side comparison of AstraZeneca PLC and RTX Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 15, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — AZN vs RTX
growth of $100 · last 30yAZN +732.9%RTX +2154.7%RTX compounded faster
AZN RTX
AZN vs RTX: by the numbers
- •AZN is the larger company ($277.22B vs $247.16B market cap).
- •AZN trades at the lower earnings multiple (26.92 vs 34.43 P/E).
- •AZN converts more revenue to profit (17.19% vs 8.03% net margin).
- •AZN grew revenue faster over the past five years (16.99% vs 8.37% CAGR).
- •AZN pays the higher dividend yield (1.79% vs 1.51%).
Which is better, AZN or RTX?
Metric tally: AZN 12 · RTX 5It depends on what you're optimizing for:
ValueAZN(lower P/E)
GrowthAZN(faster 5Y revenue CAGR)
IncomeAZN(higher dividend yield)
QualityAZN(higher ROIC)
Metrics side by side
Valuation
| Metric | AZN | RTX |
|---|---|---|
| P/E ratio | 26.92● | 34.43 |
| Forward P/E | 15.33● | 24.07 |
| P/S ratio | 4.62 | 2.77● |
| P/B ratio | 5.90 | 3.78● |
| PEG ratio | 0.14● | 0.91 |
| EV / EBITDA | 14.92● | 18.31 |
| FCF yield | 2.89% | 3.34%● |
Profitability
| Metric | AZN | RTX |
|---|---|---|
| Gross margin | 81.68%● | 20.21% |
| Operating margin | 23.69%● | 10.87% |
| Net margin | 17.19%● | 8.03% |
| ROE | 21.95%● | 10.95% |
| ROIC | 13.03%● | 6.49% |
Dividends
| Metric | AZN | RTX |
|---|---|---|
| Dividend yield | 1.79%● | 1.51% |
| Payout ratio | 48.48% | 55.18% |
Growth (annualized)
| Metric | AZN | RTX |
|---|---|---|
| Revenue CAGR (5Y) | 16.99%● | 8.37% |
| EPS CAGR (5Y) | 22.02%● | -4.16% |
| FCF CAGR (5Y) | 15.68% | 37.83%● |
| Total return CAGR (5Y) | 11.03% | 18.19%● |
Frequently asked
- Which is better, AZN or RTX?
- It depends on your goal. value: AZN (lower P/E); growth: AZN (faster 5Y revenue CAGR); income: AZN (higher dividend yield); quality: AZN (higher ROIC). Across all compared metrics, AZN leads 12 to 5.
- Is AZN or RTX cheaper?
- On trailing earnings, AZN is cheaper: AZN trades at a 26.92 P/E and RTX at 34.43.
- Which has grown faster, AZN or RTX?
- Over the past five years, AZN grew revenue faster — AZN at a 16.99% CAGR versus RTX at 8.37%.
- Does AZN or RTX pay a bigger dividend?
- AZN yields 1.79% and RTX yields 1.51% based on trailing dividends and the latest price.
- Is AZN or RTX more profitable?
- AZN runs the higher net margin — AZN at 17.19% versus RTX at 8.03%.
- Which has been the better investment, AZN or RTX?
- Over the past 10-year, AZN delivered the higher annualized total return — AZN at 15.77% versus RTX at 14.46%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AstraZeneca P/E ratioRTX P/E ratioAstraZeneca dividend yieldRTX dividend yieldAstraZeneca ROERTX ROEAstraZeneca operating marginRTX operating marginAstraZeneca revenue growthRTX revenue growthAstraZeneca free cash flowRTX free cash flow
AstraZeneca & RTX appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 15, 2026.